Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-09

FDA Approved: ATOMOXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application from Apotex Corp. to market a generic atomoxetine hydrochloride product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine hydrochloride (Atomoxetine hydrochloride)

Snippet

SUPPL AP for ATOMOXETINE HYDROCHLORIDE (ATOMOXETINE HYDROCHLORIDE)